tris(ethylenediamine)cobalt(III): RN given refers to Co(3+) ion (OC-6-11) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 122658 |
| MeSH ID | M0254320 |
| Synonym |
|---|
| cobaltic ethane-1,2-diamine |
| cobalt(3+), tris(1,2-ethanediamine-n,n')-, (oc-6-11)- |
| cobalt iii ethylenediamine |
| cobalt(3+), tris(1,2-ethanediamine-.kappa.n,.kappa.n')-, (oc-6-11)- |
| cobalt(3+), tris(ethylenediamine)-, ion |
| 14878-41-2 |
| tris(ethylenediamine)cobalt(iii) |
| co(en)3 |
| cobalt(iii) tris(ethylenediamine) |
| cobalt(3+), tris(1,2-ethanedianine-n,n')-, (oc-6-11)- |
| (oc-6-11)-tris(1,2-ethanedianine-n,n')cobalt(3+) |
| DTXSID90164100 |
| cobalt(3+);ethane-1,2-diamine |
| 1,2-ethanediamine, cobalt(3+) salt (3:1) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (54.39) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||